Thursday, Mar 28, 2024 | Last Update : 05:28 PM IST

anti-viral drug

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19

23 Jun 2020 3:47 PM

India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak

03 Jun 2020 11:57 AM

ADVERTISEMENT
ADVERTISEMENT